MedVenture and Ampersand Align to Re-capitalize Company
Officials with MedVenture Technology recently partnered with Ampersand Ventures, a Boston-based private-equity firm, to acquire the majority of MedVenture’s interests from the company’s prior investors. The transaction has led to an infusion of capital that is allowing MedVenture to grow its services and technology.
“Ampersand shares our focus on strategic growth, exceptional customer service, quality technology development and advanced manufacturing,” said Kevin Bramer, MedVenture Technology CEO. “We are now in a position to enhance our technology and innovation as we work with our clients to develop and produce some of the world’s most advanced medical devices.”
Stuart Auerbach, general partner of Ampersand, said his firm’s partnership will help MedVenture continue its record of achievement.
“MedVenture is a leader in the markets it serves and is well positioned to capitalize on future acquisition and organic growth opportunities,” he said.
